1. Home
  2. MFP vs ZYME Comparison

MFP vs ZYME Comparison

Compare MFP & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midera Food Processing Inc. Common Stock

MFP

Midera Food Processing Inc. Common Stock

N/A

Current Price

$44.85

Market Cap

1.8B

Sector

Industrials

ML Signal

N/A

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

N/A

Current Price

$30.69

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MFP
ZYME
Founded
2025
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
MFP
ZYME
Price
$44.85
$30.69
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
★ $46.67
$41.50
AVG Volume (30 Days)
409.1K
★ 1.3M
Earning Date
11-17-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.33
EPS
★ N/A
N/A
Revenue
N/A
★ $105,965,000.00
Revenue This Year
$11.60
$176.93
Revenue Next Year
$6.07
$28.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 38.87
52 Week Low
$38.51
$18.20
52 Week High
$52.58
$31.49

Technical Indicators

Market Signals
Indicator
MFP
ZYME
Relative Strength Index (RSI) 60.86 63.37
Support Level $39.58 $22.04
Resistance Level $46.15 $31.34
Average True Range (ATR) 2.04 1.19
MACD 0.36 0.22
Stochastic Oscillator 97.62 82.79

Price Performance

Historical Comparison
MFP
ZYME

About MFP Midera Food Processing Inc. Common Stock

Midera Food Processing Inc provides food processing equipment and automation solutions for industrial protein, bakery, and snack producers, delivering total line solutions from preparation and thermal processing through packaging. The company operates through a portfolio of brands and serves food processors globally. It serves various international food processing companies and producers of protein products, such as bacon, charcuterie, sausage and hot dogs, egg bites, poultry, alternative protein, lunch meat and pet food, and producers of bakery products, such as bread and buns, artisan bread, cakes and muffins, etc. The company generates revenue from the design, manufacturing and installation of food processing equipment and technology solutions and aftermarket parts and service.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: